BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 21267791)

  • 1. Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages.
    D'Avola D; Iñarrairaegui M; Pardo F; Rotellar F; Marti P; Bilbao JI; Martinez-Cuesta A; Benito A; Alegre F; Mauleón E; Herrero JI; Quiroga J; Prieto J; Sangro B
    Ann Surg Oncol; 2011 Jul; 18(7):1964-71. PubMed ID: 21267791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hepatocellular carcinoma in a tertiary Romanian center. Deviations from BCLC recommendations and influence on survival rate.
    Radu P; Groza I; Iancu C; Al Hajjar N; Andreica V; Sparchez Z
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):291-7. PubMed ID: 24078986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective validation of the Barcelona Clinic Liver Cancer staging system.
    Cillo U; Vitale A; Grigoletto F; Farinati F; Brolese A; Zanus G; Neri D; Boccagni P; Srsen N; D'Amico F; Ciarleglio FA; Bridda A; D'Amico DF
    J Hepatol; 2006 Apr; 44(4):723-31. PubMed ID: 16488051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis.
    Torzilli G; Donadon M; Marconi M; Palmisano A; Del Fabbro D; Spinelli A; Botea F; Montorsi M
    Arch Surg; 2008 Nov; 143(11):1082-90. PubMed ID: 19015467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.
    Grieco A; Pompili M; Caminiti G; Miele L; Covino M; Alfei B; Rapaccini GL; Gasbarrini G
    Gut; 2005 Mar; 54(3):411-8. PubMed ID: 15710992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.
    Heckman JT; Devera MB; Marsh JW; Fontes P; Amesur NB; Holloway SE; Nalesnik M; Geller DA; Steel JL; Gamblin TC
    Ann Surg Oncol; 2008 Nov; 15(11):3169-77. PubMed ID: 18696158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
    Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P
    J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic resection for "BCLC stage A" hepatocellular carcinoma. The prognostic role of alpha-fetoprotein.
    Santambrogio R; Opocher E; Costa M; Barabino M; Zuin M; Bertolini E; De Filippi F; Bruno S
    Ann Surg Oncol; 2012 Feb; 19(2):426-34. PubMed ID: 21732145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma.
    Dhanasekaran R; Khanna V; Kooby DA; Spivey JR; Parekh S; Knechtle SJ; Carew JD; Kauh JS; Kim HS
    J Vasc Interv Radiol; 2010 Aug; 21(8):1197-204; quiz 204. PubMed ID: 20656222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study.
    Vitale A; Morales RR; Zanus G; Farinati F; Burra P; Angeli P; Frigo AC; Del Poggio P; Rapaccini G; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Giannini EG; Caturelli E; Chiaramonte M; Trevisani F; Cillo U;
    Lancet Oncol; 2011 Jul; 12(7):654-62. PubMed ID: 21684210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma.
    Wang JH; Wang CC; Hung CH; Chen CL; Lu SN
    J Hepatol; 2012 Feb; 56(2):412-8. PubMed ID: 21756858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressive therapeutic strategies improve the survival of hepatocellular carcinoma patients with performance status 1 or 2: a propensity score analysis.
    Hsu CY; Liu PH; Lee YH; Hsia CY; Huang YH; Chiou YY; Tsai YJ; Nagaria TS; Huo TI
    Ann Surg Oncol; 2015 Apr; 22(4):1324-31. PubMed ID: 25326394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
    Ueno S; Tanabe G; Nuruki K; Oketani M; Komorizono Y; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T
    J Hepatobiliary Pancreat Surg; 2002; 9(4):469-77. PubMed ID: 12483269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems.
    Zhang XF; Qi X; Meng B; Liu C; Yu L; Wang B; Lv Y
    Eur J Surg Oncol; 2010 Aug; 36(8):718-24. PubMed ID: 20538423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of hepatocellular carcinoma: the BCLC staging classification.
    Llovet JM; Brú C; Bruix J
    Semin Liver Dis; 1999; 19(3):329-38. PubMed ID: 10518312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].
    Witjes CD; de Man RA; Eskens FA; Dwarkasing RS; Zondervan PE; Verhoef C; Ijzermans JN
    Ned Tijdschr Geneeskd; 2010; 154():A1747. PubMed ID: 20719013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival].
    Díaz-Sánchez A; Matilla A; Núñez O; Merino B; Peligros I; Rincón D; Salcedo M; Lo Iacono O; Vega Catalina M; Clemente G; Bañares R
    Gastroenterol Hepatol; 2010 Mar; 33(3):155-64. PubMed ID: 19945770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous ablative therapies of recurrent hepatocellular carcinoma after hepatectomy: proposal of a prognostic model.
    Yin XY; Xie XY; Lu MD; Kuang M; Liu GJ; Xu ZF; Xu HX; Wang Z
    Ann Surg Oncol; 2012 Dec; 19(13):4300-6. PubMed ID: 22766980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma.
    Helmberger T; Dogan S; Straub G; Schrader A; Jüngst C; Reiser M; Waggershauser T; Jakobs T; Hoffmann RT; Löhe F; Graeb C; Rau HG; Schauer R; Jauch KW; Caselmann WH; Göke B; Jüngst D
    Digestion; 2007; 75(2-3):104-12. PubMed ID: 17598962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients.
    Wang JH; Changchien CS; Hu TH; Lee CM; Kee KM; Lin CY; Chen CL; Chen TY; Huang YJ; Lu SN
    Eur J Cancer; 2008 May; 44(7):1000-6. PubMed ID: 18337087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.